Anthony Mahoney-Pacheco

About Anthony Mahoney-Pacheco

Anthony was born and raised in Fall River, MA. He is currently in his senior year at Tufts University studying Biology and Psychology. Outside of research, he volunteers his time as a member of the Tufts EMS and works as the student executive director for the Giving Camp, a local nonprofit that connects students to adults with physical and mental disabilities to take part in fun activities in the Greater Boston area. He also enjoys working as an Emergency Department technician in multiple Massachusetts hospitals.

Sarah Ganley, BS

About Sarah Ganley

Sarah completed her undergraduate degree in Behavioral Neuroscience with a minor focusing on the ethics of medical exploration during genocide from Northeastern University. Sarah comes to the team with experience in several areas of research including operational clinical research, regulatory affairs, quality assurance and control, as well as data management. The clinical fields in which she previously focused on were pharmaceuticals, dementia, autism, memory, sepsis, hospital quality assurance initiatives, infectious disease, and HIV vaccines. Since joining the Center for Resuscitation Science in December 2015, Sarah has become the point research assistant on several observational studies including one device focused study on oxygen consumption in critically ill patients. Sarah is also the point research assistant for a phase II clinical trial studying the effects of atorvastatin treatment on influenza with Dr. Chase

Michael W. Donnino, MD

About Michael Donnino

Dr. Donnino is the Founder and Director of the Center for Resuscitation Science (CRS), Director of the T32 Resuscitation Science Fellowship, Vice Chair of Resuscitation Science for the Beth Israel Deaconess Medical Center Emergency Department, and Director of Faculty Research Development.  He is a Professor of Emergency Medicine and Medicine at Harvard Medical School. Dr. Donnino is the author of over 250 manuscripts including many in high-impact journals such as the NEJM, JAMA, the British Medical Journal, and Circulation. He has been funded continuously over the past decade with support from the NIH, AHA, and other grants. His expertise spans a range of translational research with particular expertise in clinical trials. On an international level, he served as Vice-Chair and member of the Advanced Cardiac Life Support Committee for the International Liaison Committee on Resuscitation (ILCOR). In addition, he served as Vice Chair and member of the American Heart Association (AHA) cardiac arrest guideline writing group and was the senior author of the 2015 AHA ACLS guidelines. Dr. Donnino has a strong commitment to mentoring the full range of investigators from pre-medical students to junior faculty and is the recipient of the NIH Mentoring Award (K24), a T32 in Resuscitation Science as well as the Director of Faculty Research Development.

  • Cardiac Arrest (general)
  • Metabolic Resuscitation
  • Thiamine in Critical Illness
  • Challenging Cases in Critical Care
  • Challenges with Clinical Trials
  • Misapplication of Severity of Illness Scores

Michael N. Cocchi, MD

About Michael Cocchi

Dr. Cocchi currently practices as an attending physician in the emergency department and as an intensivist in the surgical intensive care units at BIDMC. After graduating from the University of Massachusetts Medical School, he completed his residency in Emergency Medicine at the Harvard Affiliated Emergency Medicine Residency at BIDMC, followed by a two-year fellowship in Critical Care Medicine. He is board certified in Emergency Medicine, Critical Care Medicine, and Neurocritical Care. His research interests have primarily focused on critical care topics, in particular cardiac arrest, sepsis, and shock. He is currently the Principal Investigator of a Phase II clinical trial studying the effects of esmolol in septic shock, funded by the American Heart Association. He is the course co-director of the biannual Harvard Shock Symposium, and has served as an evidence reviewer for the post cardiac arrest guidelines for the American Heart Association. In addition to his clinical duties and research, Dr. Cocchi’s administrative responsibilities include serving as the Director of Critical Care Quality for the Silverman Institute for Health Care Quality and Safety within the Department of Health Care Quality at BIDMC. In that role, he oversees all quality assurance-related matters, as well as quality improvement endeavors, across the 9 adult ICUs at BIDMC. He also serves as an Associate Medical Director for Boston MedFlight, an air and ground critical care transport service supporting the major teaching hospitals in Boston. A unifying theme of his clinical, research, and administrative work is improving the delivery of safe and high quality care to critically ill patients in the pre-hospital, ED and the ICU settings, in order to achieve improved outcomes for these most vulnerable patients.

Topics for Talks by Michael Cocchi

  • Updates in post arrest care
  • Proning in ARDS
  • Management status epilepticus

Maureen Chase, MD

About Maureen Chase

Dr. Maureen Chase began her research career at the Hospital of the University of Pennsylvania with a clinical research fellowship in the risk stratification of Emergency Department patients with chest pain. After joining the faculty at BIDMC, she continued her work in the early identification of patients with critical illnesses while working towards her Master in Public Health degree at the Harvard School of Public Health, publishing her work in the identification of patients with sepsis and bacteremia. She was awarded a Harvard Catalyst Pilot grant for her prospective investigation into patients with dizziness at risk for stroke that involved collaboration between the Emergency Departments at the three Harvard teaching hospitals. Via her MPH training and work within the Center for Resuscitation Science, Dr. Chase’s research focus transitioned toward early interventions for patients with critical illness. In 2013, she was awarded a K23 Mentored Patient-Oriented Research Career Development Award via the NIH/ NIGMS for her project “Statin Therapy in Acute Influenza”. The study is a randomized controlled trial assessing the effect of atorvastatin on the host inflammatory response to influenza with both clinical and laboratory endpoints.

Topics for Talks by Maureen Chase

  • Statins in Influenza
  • Basics in Clinical Trial Design and Execution